Market Place
Sourcing Support
Diversifying the Supply of Raw Materials
12 Jun 2024 //
PRESS RELEASE
Noramco Aligns with Purisys and Halo Pharma to Create Noramco Group
15 Mar 2024 //
PRESS RELEASE
Noramco Announces the Acquisition of the Cambrex Drug Product Business Unit
02 Nov 2023 //
PRESS RELEASE
Noramco Celebrates Diversity and International Women’s Day
07 Mar 2022 //
PRESS RELEASE
Noramco Announces Submission of DMF for Lisdexamfetamine Dimesylate
03 Dec 2021 //
PRESS RELEASE
Noramco celebrates Hamilton branch grand opening
10 Nov 2021 //
EBMAG
GB Sciences and Purisys Announce Preferred Supplier Relationship
20 Apr 2021 //
YAHOO
RespireRx Pharmaceuticals Appoints Timothy Jones as CEO
09 May 2020 //
NEWYORK
Delaware judge can`t tell who plaintiff worked for, so silica lawsuit continues
05 May 2020 //
LEGALNEWSLINE
How Johnson & Johnson companies used a ‘super poppy’ to make narcotics for America’s most abused opioid pills
26 Mar 2020 //
WASHINGTONPOST
Noramco to manufacture CBD to be delivered via the eye
26 Mar 2020 //
OUTSOURCING-PHARMA
RespireRx Pharmaceuticals Inc. Announces Appointment of Tim Jones to its Board of Directors
03 Feb 2020 //
GLOBENEWSWIRE
API MFG Beware – New Washington Opioid Lawsuit Targets J&J’s API Business
20 Jan 2020 //
POLICYMED
Noramco Cannabinoids Business to Become Purisys
19 Sep 2019 //
PR NEWSWIRE
Oklahoma judge rules against drugmaker, orders $572M payment
26 Aug 2019 //
HJNEWS
Noramco Presents Comments And Answers Questions At FDA Hearing On Cannabidiol
05 Jun 2019 //
NEWSWIRE
Willow Biosciences & Noramco Announce Joint Devp of Biosynthesis Cannabidiol
04 Jun 2019 //
PRESS RELEASE
Cardiol Therapeutics` Pharmaceutical Partner Noramco Presents at USFDA
03 Jun 2019 //
YAHOO
Noramco to manufacture CBD to be delivered via the eye
14 Mar 2019 //
IN-PHARMATECNOLOGIST
Nemus Bioscience Signs Agreement with Noramco to mfg Cannabidiol Analog
04 Mar 2019 //
GLOBENEWSWIRE
Noramco announces provisional patent application of proprietary cannabidiol
13 Oct 2018 //
PRESS RELEASE
Noramco and SPI Pharma target drugmakers with scalable tech
26 Apr 2018 //
IN PHARMATECHNOLOGIST
Noramco, SPI Pharma Sign Agreement
23 Apr 2018 //
PRESS RELEASE
Noramco and AFC strike deal for controlled substance APIs
22 Mar 2018 //
FIERCE PHARMA
Noramco signs AMPAC to top up API and intermediates supply
21 Mar 2018 //
IN-PHARMATECHNOLOGIST
Noramco, SPI Pharma ink collaboration to develop formulation solution packages
24 Oct 2017 //
PHARMABIZ
Noramco planning formulation tech unit alongside opioid API business
07 Mar 2017 //
IN PHARMATECHNOLOGIST
J&J seeking to divest manufacturing unit Noramco: sources
05 Jan 2016 //
REUTERS
